vimarsana.com
Home
Live Updates
FDA M-CERSI AI workshop highlights future FDA comment period
FDA M-CERSI AI workshop highlights future FDA comment period
FDA M-CERSI AI workshop highlights future FDA comment period on AI in drug development | Hogan Lovells
The U.S. Food and Drug Administration (FDA) – in collaboration with the University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) – recently hosted a...
Related Keywords
Tala Fakhouri ,
Hogan Lovells ,
Matthew Diamond ,
Duke Robertj Margolis ,
Digital Health Technologies Dhts ,
Digital Health Excellence ,
National Institute Of Standards ,
Chief Medical Officer ,
Digital Health ,
National Institute ,
Change Control ,
Machine Learning Practice ,
Medical Device ,
Associate Director ,
Policy Analysis ,
Drug Evaluation ,
Health Policy ,
Digital Health Technologies ,
Support Clinical Trials ,
Drug Development ,
Drug Omnibus Reform Act ,